Masaryk Memorial Cancer Institute
The Czech Republic's only dedicated comprehensive cancer centre, OECI-accredited and known for its RECAMO translational research centre.
The Masaryk Memorial Cancer Institute opened in 1935 as the 'House of Comfort' with the support of President Tomáš Garrigue Masaryk and is the only specialised comprehensive cancer centre in the Czech Republic, accredited by the OECI. Its Regional Centre for Applied Molecular Oncology (RECAMO), founded by Bořivoj Vojtěšek, develops antibodies and biomarkers for p53 and other targets in collaboration with Edinburgh and international groups, and the institute runs the Czech phase 1 unit for academic trials under Regina Demlová. Clinical services span surgical oncology, radiotherapy with brachytherapy and stereotactic techniques, medical oncology, nuclear medicine and a large prevention and screening centre, and the institute contributes to the national cancer registry and screening programmes.
- RECAMO translational research
- Phase 1 unit
- Prevention and screening centre
- Radiotherapy
- Surgical oncology
Pages like this
not linked directly; found by shared links- InstitutionNational Institute of Oncology, Hungary
Shares Organisation of European Cancer Institutes, Brachytherapy, Comprehensive genomic profiling, IMRT / IGRT (modern external beam).
- InstitutionInstitute of Oncology Ljubljana
Shares Organisation of European Cancer Institutes, Brachytherapy, IMRT / IGRT (modern external beam), Melanoma.
- InstitutionTel Aviv Sourasky Medical Center
Shares Comprehensive genomic profiling, IMRT / IGRT (modern external beam), Immune checkpoint inhibitors, HR-positive / HER2-negative breast cancer.
- InstitutionGhent University Hospital / Cancer Research Institute Ghent
Shares Organisation of European Cancer Institutes, Comprehensive genomic profiling, Melanoma, Immune checkpoint inhibitors.
- InstitutionMaria Skłodowska-Curie National Research Institute of Oncology
Shares Brachytherapy, IMRT / IGRT (modern external beam), Melanoma, Immune checkpoint inhibitors.
- InstitutionIstituto Oncologico Veneto IRCCS
Shares Organisation of European Cancer Institutes, Melanoma, Immune checkpoint inhibitors, HR-positive / HER2-negative breast cancer.
- InstitutionRoyal Adelaide Hospital
Shares IMRT / IGRT (modern external beam), Prostate cancer, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionInstituto Português de Oncologia do Porto Francisco Gentil
Shares Organisation of European Cancer Institutes, Brachytherapy, Prostate cancer, HR-positive / HER2-negative breast cancer.